Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine.
Level V
Where this comes from
- Record sourced from PubMed, PMID 20584544.
- Also identified by DOI 10.1016/j.jaci.2010.05.008 and PMC identifier 2917627.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This is the first study examining serotype-specific IgG responses following immunization with the polysaccharide vaccine Pneumovax<sup>®</sup> in infants aged 12 months in the absence of prior pneumococcal conjugate vaccine priming.
Medical subject headings
- Antibodies, Bacterial
- Antibody Specificity
- Immunoglobulin G
- Pneumococcal Vaccines
- Streptococcus pneumoniae